Wells Fargo & Company »

Immunitybio shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $288k 54k 5.37
2023-12-31 $258k 51k 5.02
2023-09-30 $67k 40k 1.69
2023-06-30 $178k 64k 2.78
2022-12-31 $73k 14k 5.07
2022-09-30 $97k 19k 5.19
2022-06-30 $64k 16k 3.93
2022-03-31 $748k 133k 5.61
2021-12-31 $752k 124k 6.08
2021-09-30 $1.2M 125k 9.90
2021-06-30 $2.3M 161k 14.30
2021-03-31 $1.2M 52k 23.76